BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30

• Drug Development

  Navitor Pharmaceuticals to Develop NV-5138, a Specific Activator of mTORC1 for Treatment-Resistant Depression, Based on Promising Data Presented at Society for Neuroscience 2017

  First data on NV-5138 demonstrating direct mTORC1 activation resulting in ketamine-like rapid antidepressant effects in preclinical animal models.

  November 15, 2017

   · 

  7 min read
• Drug Development

  Critical Outcome Technologies Announces Pharmacokinetic Data From Phase I Dose Escalation Portion of COTI-2 Trial in Gynecological Malignancies

  Critical Outcome Technologies today announced pharmacokinetic data from the dose-escalation portion of its Phase 1 trial of COTI-2 in gynecological malignancies that support the continued development of COTI-2 as a potential treatment for patients.

  November 15, 2017

   · 

  5 min read
• Biotech Bay

  Kalytera Announces Notice of Allowance of US Patent for Treatment of Graft Versus Host Disease

  Securing a patent for this proprietary technology represents an important step forward for the Company in its work focused on the treatment of this serious and life-threatening disease.

  November 15, 2017

   · 

  5 min read
• Business

  PAVmed Reports Third Quarter 2017 Financial Results

  Conference call to be held November 16, 2017 at 4:30 p.m. ET.

  November 15, 2017

   · 

  12 min read
• Business

  Co-Diagnostics Reports Q3 Financial Results and Updates Corporate Developments

  The company announced corporate developments and financial results for the third quarter of 2017, ended September 30, 2017.

  November 15, 2017

   · 

  7 min read
• Drug Development

  Preclinical Data Demonstrates Potential of Eidos Therapeutics’ Lead Compound for the Treatment for Transythyretin Amyloidosis

  These data were shared publicly for the first time yesterday as oral podium presentations at the AHA 2017 Annual Scientific Sessions in Anaheim, CA.

  November 15, 2017

   · 

  4 min read
• Bausch & Lomb Helps to Recycle More Than One Million Units of Contact Lens Materials Within First Year of Launching the ONE by ONE Recycling Program

  Valeant wholly owned subsidiary, Bausch & Lomb, today announced that its unique ONE by ONE Recycling Program has recycled a combined total of more than one million used contact lenses, blister packs and top foils in less than one year since its launch.

  November 15, 2017

   · 

  4 min read
• 

  FDA

  Alcyone Lifesciences Snags FDA OK for the Alivio System for the Treatment of Hydrocephalus

  This comes on the heels of Alcyone receiving the EU CE Mark last month.

  November 15, 2017

   · 

  5 min read
• Business

  Nordic Nanovector ASA - Financial Calendar

  The time and location of the presentations will be announced in due time.

  November 15, 2017

   · 

  1 min read
• Business

  Relay Therapeutics Names Sarah O’Brien as Vice President of Human Resources

  O’Brien joins Relay Therapeutics with significant strategic human resources experience in the life sciences industry.

  November 15, 2017

   · 

  2 min read